title: Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
abstract: Telephone disclosure of BRCA1/2 molecular genetic test results has been proposed as a feasible alternative to traditional in-person results disclosure. The purpose of this study was to investigate the relationship between method of result disclosure with the patient outcome variables of knowledge, cancer worry, cancer risk perception, satisfaction, and cancer screening and prophylactic surgery behaviors. Study participants included 228 women who completed retrospective, self-administered, mailed surveys regarding their pre-test genetic counseling and results disclosure. No significant relationships were found between result disclosure method and the outcome variables investigated. A majority (90%) of individuals who received positive results by telephone returned for follow up visits. Factors which genetic counselors believed influenced their clinical decision to offer telephone disclosure, such as history of breast cancer, a priori risk of genetic mutation and family history of known mutation were not shown to significantly impact the actual disclosure method. This study suggests that telephone results disclosure is clinically appropriate when counselors utilize their clinical judgment to determine which patients are appropriate candidates.
authors.affiliation: Genetic Counseling Graduate Program, College of Allied Health Sciences, University of Cincinnati, Cincinnati, OH, USA.
authors.forename: Courtney
authors.initials: C
authors.lastname: Doughty Rice
authors.forename: Jennifer Gamm
authors.initials: JG
authors.lastname: Ruschman
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Martin
authors.forename: Jennifer B
authors.initials: JB
authors.lastname: Manders
authors.forename: Erin
authors.initials: E
authors.lastname: Miller
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics / Q000523:psychology*; D030881:Disclosure / Q000331:legislation & jurisprudence; D005260:Female; D019398:Genes, BRCA1 / Q000502:physiology*; D024522:Genes, BRCA2 / Q000502:physiology; D005817:Genetic Counseling / Q000523:psychology*; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000379:methods*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007258:Informed Consent / Q000523:psychology; D008297:Male; D018907:Privacy; D012189:Retrospective Studies; D013689:Telephone; D016896:Treatment Outcome
chemical_list: D019313:BRCA1 Protein
references.citation: N Engl J Med. 1997 May 15;336(20):1409-15
references.pmid: 9145677
references.citation: Health Psychol. 1991;10(4):259-67
references.pmid: 1915212
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1893-8
references.pmid: 17035396
references.citation: Am J Med Genet A. 2003 Jan 1;116A(1):11-9
references.pmid: 12476445
references.citation: Am J Med Genet. 1990 Dec;37(4):522-9
references.pmid: 2260600
references.citation: Fam Cancer. 2005;4(4):279-84
references.pmid: 16341803
references.citation: J Genet Couns. 2007 Jun;16(3):241-60
references.pmid: 17508274
references.citation: JAMA. 1996 Jun 26;275(24):1885-92
references.pmid: 8648868
references.citation: Fam Pract. 2001 Apr;18(2):135-40
references.pmid: 11264262
references.citation: Patient Educ Couns. 2006 Dec;64(1-3):96-103
references.pmid: 16427245
references.citation: Psychooncology. 2000 Jan-Feb;9(1):44-56
references.pmid: 10668059
references.citation: Oncol Nurs Forum. 2006 Jan 01;33(1):138-44
references.pmid: 16470242
references.citation: Am J Med Genet A. 2005 Aug 15;137(1):27-35
references.pmid: 16007615
references.citation: Qual Health Res. 2000 Jul;10(4):507-20
references.pmid: 11010075
references.citation: Patient Educ Couns. 1999 May;37(1):3-18
references.pmid: 10640115
references.citation: Genet Med. 2007 Aug;9(8):487-95
references.pmid: 17700386
references.citation: J Clin Oncol. 2002 Mar 15;20(6):1480-90
references.pmid: 11896095
references.citation: J Clin Oncol. 2002 Nov 15;20(22):4485-92
references.pmid: 12431973
references.citation: JAMA. 2008 Mar 19;299(11):1320-34
references.pmid: 18349093
references.citation: Breast J. 2008 Jan-Feb;14(1):3-13
references.pmid: 18086272
references.citation: J Genet Couns. 2009 Oct;18(5):447-63
references.pmid: 19462222
references.citation: J Genet Couns. 2004 Apr;13(2):83-114
references.pmid: 15604628
references.citation: J Genet Couns. 2003 Apr;12(2):171-84
references.pmid: 26140847
references.citation: J Genet Couns. 2000 Feb;9(1):63-71
references.pmid: 26141085
references.citation: J Mol Med (Berl). 2006 Jan;84(1):16-28
references.pmid: 16283147
references.citation: Cancer. 1996 Jun 1;77(11):2318-24
references.pmid: 8635102
references.citation: Am J Med Genet A. 2006 Oct 15;140(20):2198-206
references.pmid: 16969872
references.citation: J Genet Couns. 2000 Feb;9(1):73-82
references.pmid: 26141086
references.citation: Science. 1994 Sep 30;265(5181):2088-90
references.pmid: 8091231
references.citation: Surg Oncol. 2002 May;10(4):183-92
references.pmid: 12020673
references.citation: Science. 1990 Dec 21;250(4988):1684-9
references.pmid: 2270482
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2397-406
references.pmid: 12692171